Charles A. Reasner
Negative results from the ENHANCE trial and the delay in reporting the findings have caused to question the efficacy of ezetimibe and the integrity of the drug’s manufacturer. The Editor highlights the salient points of the results, the controversy they generated, and his own take on this.
Drug treatment — Cholesterol-lowering drugs
Irene Folaron, M.D., Capt., U.S.A.F., M.C., and Tom Sauerwein, M.D., Lt. Col., U.S.A.F., M.C.
Hyperinsulinemic hypoglycemia has recently emerged as a chronic complication of the Roux-en-Y bypass, the most common bariatric procedure in the United States. The authors offer a thorough and enlightening explanation of the possible mechanisms, as well as guidelines for diagnosis and treatment.
Surgery and hospital care — Bariatric surgery
Complications and comorbidities — Obesity
Krisha S. Kasturi, M.B.B.S., M.P.H, and John R. Petersen, Ph.D., D.A.B.C.C., F.A.C.B.
The authors provide compelling evidence that point-of-care HbA1c results can verify the accuracy of home testing, provide a more accurate picture of glycemic control, allows timely decisions regarding changes in therapy, and thereby improve the management of diabetes.
Management strategies and tools — HbA1c testing
Management strategies and tools — Strategies for glycemic control
Allen B. King, M.D., C.D.E.
Moderate daily alcohol intake has been shown to have significant benefit to people with diabetes, but are there drawbacks? This article reviews the risks and benefits of moderate alcohol intake and recommendations that practitioners should make for their diabetic patients.
Diet therapy and nutrition
Management strategies and tools
Jeff Unger, M.D.
People who present with clinical features of Type 2 diabetes may actually have latent autoimmune diabetes, a slowly progressive subtype of Type 1. Dr. Unger explains how to screen for this and how to treat to preserve beta-cell function and minimize long-term complications.
Latent autoimmune diabetes of adults